{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:07:36Z","timestamp":1793210856902,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000924","name":"Multiple Sclerosis Research Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00415-020-10194-x","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T12:03:33Z","timestamp":1599134613000},"page":"602-612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosis"],"prefix":"10.1007","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8522-6476","authenticated-orcid":false,"given":"Lara Marie Pangan","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce V.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Winzenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Blizzard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9009-7472","authenticated-orcid":false,"given":"Ingrid","family":"van der Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"issue":"4","key":"10194_CR1","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s13311-017-0548-5","volume":"14","author":"AL Smith","year":"2017","unstructured":"Smith AL, Cohen JA, Hua LH (2017) Therapeutic targets for multiple sclerosis: current treatment goals and future directions. Neurotherapeutics 14(4):952\u2013960. https:\/\/doi.org\/10.1007\/s13311-017-0548-5","journal-title":"Neurotherapeutics"},{"issue":"CD006036","key":"10194_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/14651858.CD006036.pub2","volume":"2","author":"F Khan","year":"2007","unstructured":"Khan F, Turner-Stokes L, Ng L, Kilpatrick T (2007) Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database Syst Rev 2(CD006036):385. https:\/\/doi.org\/10.1002\/14651858.CD006036.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"10194_CR3","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S1474-4422(10)70135-6","volume":"9","author":"RA Marrie","year":"2010","unstructured":"Marrie RA, Horwitz RI (2010) Emerging effects of comorbidities on multiple sclerosis. Lancet Neurol 9:820\u2013828. https:\/\/doi.org\/10.1016\/S1474-4422(10)70135-6","journal-title":"Lancet Neurol"},{"issue":"15","key":"10194_CR4","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1212\/WNL.0000000000002471","volume":"86","author":"RA Marrie","year":"2016","unstructured":"Marrie RA, Miller A, Sormani MP, Thompson A, Waubant E, Trojano M, O'Connor P, Reingold S, Cohen JA, For the attendees of the International Workshop on Comorbidity in Multiple S (2016) The challenge of comorbidity in clinical trials for multiple sclerosis. Neurology 86(15):1437\u20131445. https:\/\/doi.org\/10.1212\/WNL.0000000000002471","journal-title":"Neurology"},{"key":"10194_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nrneurol.2017.33","volume":"13","author":"RA Marrie","year":"2017","unstructured":"Marrie RA (2017) Comorbidity in multiple sclerosis: implications for patient care. Nat Rev Neurol 13:375. https:\/\/doi.org\/10.1038\/nrneurol.2017.33","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"10194_CR6","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1177\/1054773815592817","volume":"25","author":"PK Newland","year":"2015","unstructured":"Newland PK, Lorenz R, Budhathoki C, Jensen MP (2015) The presence of symptoms with comorbid conditions in individuals with multiple sclerosis (MS). Clin Nurs Res 25(5):532\u2013548. https:\/\/doi.org\/10.1177\/1054773815592817","journal-title":"Clin Nurs Res"},{"issue":"15","key":"10194_CR7","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1212\/WNL.0000000000002564","volume":"86","author":"LI Berrigan","year":"2016","unstructured":"Berrigan LI, Fisk JD, Patten SB, Tremlett H, Wolfson C, Warren S, Fiest KM, McKay KA, Marrie RA, For the CIHR Team in the Epidemiology Impact of Comorbidity on Multiple Sclerosis (ECoMS) (2016) Health-related quality of life in multiple sclerosis: direct and indirect effects of comorbidity. Neurology 86(15):1417\u20131424. https:\/\/doi.org\/10.1212\/WNL.0000000000002564","journal-title":"Neurology"},{"issue":"5","key":"10194_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1212\/cpj.0000000000000269","volume":"6","author":"A Salter","year":"2016","unstructured":"Salter A, Tyry T, Wang G, Fox RJ, Cutter G, Marrie RA (2016) Examining the joint effect of disability, health behaviors, and comorbidity on mortality in MS. Neurol Clin Pract 6(5):397\u2013408. https:\/\/doi.org\/10.1212\/cpj.0000000000000269","journal-title":"Neurol Clin Pract"},{"issue":"3","key":"10194_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1352458514564491","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Cohen J, Stuve O, Trojano M, Sorensen PS, Reingold S, Cutter G, reider N, (2015) A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scler J 21(3):263\u2013281. https:\/\/doi.org\/10.1177\/1352458514564491","journal-title":"Mult Scler J"},{"issue":"2","key":"10194_CR10","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1177\/1352458511414041","volume":"17","author":"RA Marrie","year":"2011","unstructured":"Marrie RA, Cutter G, Tyry T (2011) Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis. Mult Scler J 17(2):1464\u20131471. https:\/\/doi.org\/10.1177\/1352458511414041","journal-title":"Mult Scler J"},{"key":"10194_CR11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000442203","volume":"46","author":"P Tettey","year":"2016","unstructured":"Tettey P, Siejka D, Simpson S Jr, Taylor B, Blizzard L, Ponsonby A-L, Dwyer T, van der Mei I (2016) Frequency of comorbidities and their association with\nclinical disability and relapse in multiple sclerosis. Neuroepidemiology 46:106\u2013113. https:\/\/doi.org\/10.1159\/000442203","journal-title":"Neuroepidemiology"},{"issue":"3","key":"10194_CR12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1177\/1352458514564485","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Reider N, Cohen J, Stuve O, Trojano M, Cutter G, Reingold S, Sorensen PS (2015) A systematic review of the incidence and prevalence of cardiac, cerebrovascular and peripheral vascular disease in multiple sclerosis. Mult Scler J 21(3):318\u2013331. https:\/\/doi.org\/10.1177\/1352458514564485","journal-title":"Mult Scler J"},{"issue":"2","key":"10194_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1600-0404.2010.01436.x","volume":"124","author":"RA Marrie","year":"2010","unstructured":"Marrie RA, Horwitz R, Cutter G, Tyry T, Vollmer T (2010) Association between comorbidity and clinical characteristics of MS. Acta Neurol Scand 124(2):135\u2013141. https:\/\/doi.org\/10.1111\/j.1600-0404.2010.01436.x","journal-title":"Acta Neurol Scand"},{"key":"10194_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1365-2249.2006.03235.x","volume":"146","author":"AL Ponsonby","year":"2006","unstructured":"Ponsonby AL, Dwyer T, van der Mei I, Blizzard L, Taylor B, Kilpatrick T, Simmons R (2006) Asthma onset prior to multiple sclerosis and the contribution of sibling exposure in early life. Clin Exp Immunol 146:463\u2013470. https:\/\/doi.org\/10.1111\/j.1365-2249.2006.03235.x","journal-title":"Clin Exp Immunol"},{"issue":"14","key":"10194_CR15","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1212\/WNL.0000000000002481","volume":"86","author":"RA Marrie","year":"2016","unstructured":"Marrie RA, Patten SB, Tremlett H, Wolfson C, Warren S, Svenson LW, Jette N, Fisk J, Epidemiology CTit, Impact of Comorbidity on Multiple S (2016) Sex differences in comorbidity at diagnosis of multiple sclerosis: a population-based study. Neurology 86(14):1279\u20131286. https:\/\/doi.org\/10.1212\/WNL.0000000000002481","journal-title":"Neurology"},{"issue":"8","key":"10194_CR16","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1177\/1352458518783662","volume":"25","author":"JMA Wijnands","year":"2018","unstructured":"Wijnands JMA, Zhu F, Kingwell E, Zhao Y, Ekuma O, Lu X, Evans C, Fisk JD, Marrie RA, Tremlett H (2018) Five years before multiple sclerosis onset: phenotyping the prodrome. Mult Scler J 25(8):1092\u20131101. https:\/\/doi.org\/10.1177\/1352458518783662","journal-title":"Mult Scler J"},{"issue":"11","key":"10194_CR17","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/ene.12518","volume":"21","author":"H Roshanisefat","year":"2014","unstructured":"Roshanisefat H, Bahmanyar S, Hillert J, Olsson T, Montgomery S (2014) Multiple sclerosis clinical course and cardiovascular disease risk\u2014Swedish cohort study. Eur J Neurol 21(11):1353\u2013e1388. https:\/\/doi.org\/10.1111\/ene.12518","journal-title":"Eur J Neurol"},{"issue":"10","key":"10194_CR18","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1177\/1352458513475833","volume":"19","author":"E Jadidi","year":"2013","unstructured":"Jadidi E, Mohammadi M, Moradi T (2013) High risk of cardiovascular diseases after diagnosis of multiple sclerosis. Mult Scler J 19(10):1336\u20131340. https:\/\/doi.org\/10.1177\/1352458513475833","journal-title":"Mult Scler J"},{"key":"10194_CR19","doi-asserted-by":"publisher","first-page":"817238","DOI":"10.1155\/2015\/817238","volume":"2015","author":"KA McKay","year":"2015","unstructured":"McKay KA, Kwan V, Duggan T, Tremlett H (2015) Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic review. Biomed Res Int 2015:817238\u2013817238. https:\/\/doi.org\/10.1155\/2015\/817238","journal-title":"Biomed Res Int"},{"key":"10194_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09395-w","author":"H Li","year":"2019","unstructured":"Li H, Hu F, Zhang Y, Li K (2019) Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing-remitting multiple sclerosis: a systematic review and network meta-analysis. J Neurol. https:\/\/doi.org\/10.1007\/s00415-019-09395-w","journal-title":"J Neurol"},{"issue":"12","key":"10194_CR21","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1177\/1352458513481511","volume":"19","author":"BV Taylor","year":"2013","unstructured":"Taylor BV, Palmer A, Simpson S Jr, Lucas R, Group NS, Simmons RD, Mason D, Pearson J, Clarke G, Sabel C, Willoughby E, Richardson A, Abernethy D (2013) Assessing possible selection bias in a national voluntary MS longitudinal study in Australia. Mult Scler J 19(12):1627\u20131631. https:\/\/doi.org\/10.1177\/1352458513481511","journal-title":"Mult Scler J"},{"issue":"2","key":"10194_CR22","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302. https:\/\/doi.org\/10.1002\/ana.22366","journal-title":"Ann Neurol"},{"issue":"1","key":"10194_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"WI McDonald","year":"2001","unstructured":"McDonald WI, Compston A, Edan G, Goodkin D, Hartung H-P, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, Svd N, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121\u2013127. https:\/\/doi.org\/10.1002\/ana.1032","journal-title":"Ann Neurol"},{"key":"10194_CR24","unstructured":"National Health Survey 2014-2015: Users' guide (cat.no. 4364.0.55.001) (2015). www.abs.gov.au. Accessed 20 Oct 2017"},{"issue":"9","key":"10194_CR25","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1111\/j.1468-1331.2010.02971.x","volume":"17","author":"JH Kang","year":"2010","unstructured":"Kang JH, Chen YH, Lin HC (2010) Comorbidities amongst patients with multiple sclerosis: a population-based controlled study. Eur J Neurol 17(9):1215\u20131219. https:\/\/doi.org\/10.1111\/j.1468-1331.2010.02971.x","journal-title":"Eur J Neurol"},{"key":"10194_CR26","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1177\/1352458508092263","volume":"14","author":"R Marrie","year":"2008","unstructured":"Marrie R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T (2008) Comorbidity, socioeconomic status and multiple sclerosis. Mult Scler 14:1091\u20131098. https:\/\/doi.org\/10.1177\/1352458508092263","journal-title":"Mult Scler"},{"key":"10194_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1212\/01.wnl.0000333252.78173.5f","volume":"72","author":"RA Marrie","year":"2009","unstructured":"Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T (2009) Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology 72:117\u2013124. https:\/\/doi.org\/10.1212\/01.wnl.0000333252.78173.5f","journal-title":"Neurology"},{"key":"10194_CR28","unstructured":"National Institute for Health Care Excellence (2016) Multimorbidity: clinical assessment and management. https:\/\/www.nice.org.uk\/guidance\/ng56. Accessed 22 Jun 2019"},{"key":"10194_CR29","unstructured":"Marrie RA (2018) Comorbidities in Multiple Sclerosis: A Clinical Resource Guide. The Consortium of Multiple Sclerosis Centers (CMSC); Nurse Practitioner Alternatives (NPA); Catamount Medical Education. https:\/\/mscomorbidities.com\/. Accessed 17 Mar 2018"},{"key":"10194_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.01074","author":"TJ Weiland","year":"2018","unstructured":"Weiland TJ, De Livera AM, Brown CR, Jelinek GA, Aitken Z, Simpson SL, Neate SL, Taylor KL, O'Kearney E, Bevens W, Marck CH (2018) Health outcomes and lifestyle in a sample of people with multiple sclerosis (HOLISM): longitudinal and validation cohorts. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2018.01074","journal-title":"Front Neurol"},{"issue":"3","key":"10194_CR31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1600-0404.2011.01526.x","volume":"125","author":"RA Marrie","year":"2012","unstructured":"Marrie RA, Horwitz R, Cutter G, Tyry T (2012) Cumulative impact of comorbidity on quality of life in MS. Acta Neurol Scand 125(3):180\u2013186. https:\/\/doi.org\/10.1111\/j.1600-0404.2011.01526.x","journal-title":"Acta Neurol Scand"},{"key":"10194_CR32","unstructured":"MS Brain Health (2019) Brain health: time matters in multiple sclerosis. Oxford Health Policy Forum CIC. https:\/\/www.msbrainhealth.org\/. Accessed 22 Jan 2019"},{"issue":"3","key":"10194_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/1352458514564487","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Reingold S, Cohen J, Stuve O, Trojano M, Sorensen PS, Cutter G, Reider N (2015) The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler J 21(3):305\u2013317. https:\/\/doi.org\/10.1177\/1352458514564487","journal-title":"Mult Scler J"},{"issue":"1","key":"10194_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1177\/1352458511416487","volume":"18","author":"K Ilya","year":"2011","unstructured":"Ilya K, Kassandra LM, Joseph H, Alberto A (2011) Increased risk of multiple sclerosis among women with migraine in the Nurses\u2019 Health Study II. Mult Scler J 18(1):90\u201397. https:\/\/doi.org\/10.1177\/1352458511416487","journal-title":"Mult Scler J"},{"issue":"3\u20134","key":"10194_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000381212","volume":"73","author":"T Koudriavtseva","year":"2015","unstructured":"Koudriavtseva T, Renna R, Mandoj C, Piattella MC, Plantone D, Giannarelli D (2015) Association between anemia and multiple sclerosis. Eur Neurol 73(3\u20134):233\u2013237. https:\/\/doi.org\/10.1159\/000381212","journal-title":"Eur Neurol"},{"key":"10194_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.msard.2017.02.012","volume":"13","author":"RA Marrie","year":"2017","unstructured":"Marrie RA, Patten SB, Tremlett H, Wolfson C, Leung S, Fisk JD (2017) Increased incidence and prevalence of psoriasis in multiple sclerosis. Mult Scler Relat Disord 13:81\u201386. https:\/\/doi.org\/10.1016\/j.msard.2017.02.012","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"10194_CR37","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1191\/1352458505ms1188oa","volume":"11","author":"RW Motl","year":"2005","unstructured":"Motl RW, McAuley E, Snook EM (2005) Physical activity and multiple sclerosis: a meta-analysis. Mult Scler J 11(4):459\u2013463. https:\/\/doi.org\/10.1191\/1352458505ms1188oa","journal-title":"Mult Scler J"},{"key":"10194_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000327749","volume":"36","author":"RW Motl","year":"2011","unstructured":"Motl RW, Fernhall B, McAuley E, Cutter G (2011) Physical activity and self-reported cardiovascular comorbidities in persons with multiple sclerosis: evidence from a cross-sectional analysis. Neuroepidemiology 36:183\u2013191. https:\/\/doi.org\/10.1159\/000327749","journal-title":"Neuroepidemiology"},{"issue":"7","key":"10194_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamaneurol.2020.0664","volume":"77","author":"R Palladino","year":"2020","unstructured":"Palladino R, Marrie RA, Majeed A, Chataway J (2020) Evaluating the risk of macrovascular events and mortality among people with multiple sclerosis in England. JAMA Neurol 77(7):1\u20139. https:\/\/doi.org\/10.1001\/jamaneurol.2020.0664","journal-title":"JAMA Neurol"},{"issue":"8","key":"10194_CR40","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s40263-014-0173-3","volume":"28","author":"S Gupta","year":"2014","unstructured":"Gupta S, Ahsan I, Mahfooz N, Abdelhamid N, Ramanathan M, Weinstock-Guttman B (2014) Osteoporosis and multiple sclerosis: risk factors, pathophysiology and therapeutic interventions. CNS Drugs 28(8):731\u2013742. https:\/\/doi.org\/10.1007\/s40263-014-0173-3","journal-title":"CNS Drugs"},{"issue":"4","key":"10194_CR41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1056\/NEJMct1101691","volume":"366","author":"D Pelletier","year":"2012","unstructured":"Pelletier D, Hafler DA (2012) Fingolimod for multiple sclerosis. N Engl J Med 366(4):339\u2013347. https:\/\/doi.org\/10.1056\/NEJMct1101691","journal-title":"N Engl J Med"},{"issue":"3","key":"10194_CR42","first-page":"180","volume":"15","author":"SM Baghbanian","year":"2016","unstructured":"Baghbanian SM (2016) Follow-up of hypertension in patients with multiple sclerosis. Iran J Neurol 15(3):180\u2013181","journal-title":"Iran J Neurol"},{"issue":"2","key":"10194_CR43","doi-asserted-by":"publisher","first-page":"e1026","DOI":"10.1038\/tp.2016.274","volume":"7","author":"WC Chiu","year":"2017","unstructured":"Chiu WC, Su YP, Su KP, Chen PC (2017) Recurrence of depressive disorders after interferon-induced depression. Transl Psychiatry 7(2):e1026\u2013e1026. https:\/\/doi.org\/10.1038\/tp.2016.274","journal-title":"Transl Psychiatry"},{"issue":"2","key":"10194_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1600-0404.2011.01532.x","volume":"125","author":"F Patti","year":"2012","unstructured":"Patti F, Nicoletti A, Pappalardo A, Castiglione A, Fermo SL, Messina S, D\u2019Amico E, Cimino V, Zappia M (2012) Frequency and severity of headache is worsened by Interferon-\u03b2 therapy in patients with multiple sclerosis. Acta Neurol Scand 125(2):91\u201395. https:\/\/doi.org\/10.1111\/j.1600-0404.2011.01532.x","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"10194_CR45","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1177\/1352458514564488","volume":"21","author":"RA Marrie","year":"2014","unstructured":"Marrie RA, Reider N, Cohen J, Stuve O, Trojano M, Cutter G, Reingold S, Sorensen PS (2014) The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: a systematic review. Mult Scler J 21(3):332\u2013341. https:\/\/doi.org\/10.1177\/1352458514564488","journal-title":"Mult Scler J"},{"issue":"1","key":"10194_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/ene.13786","volume":"26","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Taylor BV, Simpson S Jr, Blizzard L, van der Mei I (2019) Patient-reported outcomes are worse for progressive-onset multiple sclerosis than relapse-onset multiple sclerosis, particularly early in the disease process. Eur J Neurol 26(1):155\u2013161. https:\/\/doi.org\/10.1111\/ene.13786","journal-title":"Eur J Neurol"},{"issue":"7","key":"10194_CR47","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1177\/1352458517711274","volume":"24","author":"A Salter","year":"2017","unstructured":"Salter A, Thomas NP, Tyry T, Cutter GR, Marrie RA (2017) A contemporary profile of primary progressive multiple sclerosis participants from the NARCOMS Registry. Mult Scler J 24(7):951\u2013962. https:\/\/doi.org\/10.1177\/1352458517711274","journal-title":"Mult Scler J"},{"issue":"22","key":"10194_CR48","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1212\/WNL.0000000000002174","volume":"85","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Fisk JD, Tremlett H, Wolfson C, Warren S, Tennakoon A, Leung S, Patten SB, On behalf of the CTitE, Impact of Comorbidity on Multiple S (2015) Differences in the burden of psychiatric comorbidity in MS vs the general population. Neurology 85(22):1972\u20131979. https:\/\/doi.org\/10.1212\/WNL.0000000000002174","journal-title":"Neurology"},{"issue":"9","key":"10194_CR49","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1177\/1352458512437814","volume":"18","author":"RA Marrie","year":"2012","unstructured":"Marrie RA, Yu BN, Leung S, Elliott L, Caetano P, Warren S, Wolfson C, Patten SB, Svenson LW, Tremlett H, Fisk J, Blanchard JF (2012) Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia. Mult Scler J 18(9):1310\u20131319. https:\/\/doi.org\/10.1177\/1352458512437814","journal-title":"Mult Scler J"},{"key":"10194_CR50","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519861270","author":"JA Campbell","year":"2019","unstructured":"Campbell JA, Simpson S, Ahmad H, Taylor BV, van der Mei I, Palmer AJ (2019) Change in multiple sclerosis prevalence over time in Australia 2010\u20132017 utilising disease-modifying therapy prescription data. Mult Scler J. https:\/\/doi.org\/10.1177\/1352458519861270","journal-title":"Mult Scler J"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10194-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-10194-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10194-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T22:29:02Z","timestamp":1630708142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-10194-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10194"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-10194-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"assertion":[{"value":"5 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}